博拓生物: 博拓生物关于完成工商变更登记并换发营业执照的公告

Group 1 - The company has completed the registration of business changes and obtained a new business license from the Zhejiang Provincial Market Supervision Administration [2] - The company held its 2024 annual general meeting on May 16, 2025, where it approved the profit distribution and capital reserve conversion plan for 2024, which was implemented on June 6, 2025 [1] - The company held its second extraordinary general meeting of 2025 on June 4, 2025, where it approved the cancellation of the supervisory board, expansion of business scope, and amendments to the articles of association [2] Group 2 - The company's registered capital is 149,333,334 yuan, and its business scope includes various technical services, medical device sales, and electronic component manufacturing [2] - The company is classified as a listed other joint-stock company with a unified social credit code of 9133010079969193XF [2] - The company’s business activities encompass a wide range of sectors, including technology development, medical equipment, and electronic products [2]